Voyager Therapeutics Inc
NASDAQ:VYGR
| Market Cap (Intraday) | 221.26M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $4.01 |
| 50-Day MA | $3.46 |
| 200-Day MA | $4.09 |
Voyager Therapeutics Inc Stock, NASDAQ:VYGR
75 Hayden Avenue, Lexington, Massachusetts 02421
United States of America
Phone: +1.857.259.5340
Number of Employees: 162
Description
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.